Latest Articlesddd

IONIS: Near Reaching the Hall of Fame

December 21, 2016 0

Ionis Pharmaceuticals (IONS) has further good news with a new revelation from Akcea Therapeutics, a wholly-owned …

Prohost Letter #403 Part 2

December 16, 2016 0

Prohost Letter #403 Part 2 Continued From Wednesday Instead of continuing yesterday article about Agenus, we …

Prohost Letter #403 Part 1

December 14, 2016 0

ProhostLetter #403 Part 1 On December 8, 2016 under News & Comments Prohost commented on President …

Ophthotech Bad News Adds to Regeneron Good News

December 12, 2016 0

Today we have good news and bad news. The good news is coming from Regeneron (REGN)through two …

Prohost Take on What’s Going on in the Drug Sector

December 8, 2016 0

President Elect Trump was quoted in a Time person of the year as saying “I am …

Bellicum Is Outperforming and So Should Be Its Stock

December 5, 2016 0

Bellicum Pharmaceuticals (BLCM) announced results from the BP-004 multicenter clinical trial for children with Primary Immune …

Prohost Letter #402

November 30, 2016 0

Prohost Letter #402 Antisense Proof of Concept and Feasibility EYE ON INVIVA (INVA) Sales of The …

It Is All About Array Biopharma

November 22, 2016 0

Prohost Biotech On   ARRAY PHARMACEUTICALS Under the title “Halozyme has Good News and Array Too”, we …

Prohost Letter #401

November 16, 2016 0

Prohost Letter #401 SYNOPSIS PART 1 In this Letter CONTENTS Duchenne Muscular Dystrophy (DMD) FDA Compassionate …

Adaptimmune: The FDA Removed the Temporary Ban on the Trial with NY-ESOS PEAR T-Cell Therapy for Mixoid Round Cell Liposarcoma

November 14, 2016 0

The U.S. Food and Drug Administration (FDA) has removed the partial clinical hold it put on …

PTC Therapeutics Stock Price Doubles. When the Data Are Not Good for Forecasting.

November 11, 2016 0

The media failure to forecast the results of the Presidential election has become the talk of …

Ionis Drug Spinraza Conquers Spinal Muscular Atrophy with Statistically Significant Results

November 8, 2016 0

Biogen (BIIB) and Ionis (IONS) announced that Spinraza (nusinersen), an antisense drug designed and developed by …

Cempra Stock has Been Cremated. Will Today’s Good News Resurrect It?

November 7, 2016 0

The nature the Presidential Election this time is weighing on investors’ chests and minds and mood …

Ariad Pharmaceuticals: Substantiating Its Solid Scientific Fundamentals and the Value of Its Strategy

November 1, 2016 0

Ariad Pharmaceuticals (ARIA): Good news from the U.S. Food and Drug Administration (FDA) affirmed that the …

Regeneron and Sanofi Rheumatoid Arthritis Drug is Still Extremely Promising

October 31, 2016 0

Regeneron (REGN) and Sanofi informed that the FDA has issued a Complete Response Letter (CRL) regarding …

Prohost Letter #400

October 27, 2016 0

Prohost Letter #400 NEAR-­TERM INVESTING The Prohost Letter #399 Part 3 has Promised to Des

Gilead’s Positive News Exceeds By-Far Its Negative News. Who Said Gilead Needs Acquisitions to Maintain Its Growth?

October 21, 2016 0

Results from trials were negative in two phase 2 studies for Gilead (GILD) experimental drug GS-4997 …

Why We Are Ignoring the Temporary Selling of NKTR. See Also: Agenus Adjuvant in GSK Successful Shingles Vaccine

October 19, 2016 0

There is nothing wrong with Nektar Therapeutics (NKTR). The stock is temporarily underperforming as traders are …

Incyte and Lilly: Conquering Rheumatoid Arthritis

October 18, 2016 0

At the Annual European Congress of Rheumatology (EULAR 2016) in London, Eli Lilly and Company (LLY) …

Senator Sanders and Ariad

October 17, 2016 0

Shares of Ariad Pharmaceuticals declined following Senator Bernie Sanders’ criticism of the high price of the …